Clinical trial
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain, With or Without Aura, and the Prevention of Migraine Associated Nausea and Vomiting.
NCT03877718 is registered in ClinicalTrials.gov with Charleston Laboratories, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain, With or Without Aura, and the Prevention of Migraine Associated Nausea and Vomiting.
- Lead sponsor
- Charleston Laboratories, Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 1, 2019
- Completion date
- August 27, 2019
- Enrollment
- 475 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.